Hakmook Kang
Last active: 4/6/2017

Quantitative [F]FMISO PET Imaging Shows Reduction of Hypoxia Following Trastuzumab in a Murine Model of HER2+ Breast Cancer.

Sorace AG, Syed AK, Barnes SL, Quarles CC, Sanchez V, Kang H, Yankeelov TE
Mol Imaging Biol. 2017 19 (1): 130-137

PMID: 27506906 · PMCID: PMC5214951 · DOI:10.1007/s11307-016-0994-1

MeSH Terms (14)

Animals Biomarkers, Tumor Cell Line, Tumor Disease Models, Animal Female Fluorescent Antibody Technique Mammary Neoplasms, Animal Misonidazole Nitroimidazoles Positron-Emission Tomography Receptor, ErbB-2 Trastuzumab Tumor Burden Tumor Hypoxia

Connections (1)

This publication is referenced by other Labnodes entities: